Ocrevus subcutaneous

Roche’s Ocrevus shows similar efficacy and safety in subcutaneous and intravenous forms

Roche’s innovative subcutaneous adaptation of its highly-regarded multiple sclerosis (MS) medication, Ocrevus, has achieved a significant breakthrough in a pivotal ...